Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03809845 Completed - Clinical trials for Motor Neuron Disease

Serial Fasciculation Measurements in Motor Neurone Disease

Start date: July 6, 2017
Phase: N/A
Study type: Interventional

Patients with motor neurone disease (MND) typically experience relentless motor decline and die within three years of symptom onset from respiratory muscle weakness. There are currently no effective therapies and the discovery of novel therapies is hampered by the lack of a sensitive disease biomarker. Consequently, there is a huge drive to discover novel biomarkers, which can reliably track disease progression over time. These can then be incorporated into clinical drug trials to expedite effective drug discovery. Muscle fasciculations represent the hyperexcitability of diseased motor neurons and are almost universally present from the early stages of MND. The investigators predict that the site, frequency and shape of fasciculations might provide a sensitive measure of disease progression in an individual. In order to calibrate this technique, the investigators will conduct a 12-month longitudinal study, recruiting 24 patients from the King's College Hospital Motor Nerve Clinic, comprising a mixture of patients with MND and those with benign fasciculation syndrome. Patients in this latter group have fasciculations but do not develop weakness and have normal lifespans. They are therefore an optimal control group. At each visit, the investigators will take resting HDSEMG recordings from all four limbs and perform standard clinical measures of disease progression. The investigators will also monitor the decline in motor unit number using a newly validated neurophysiological technique, called Motor Unit Number Index (MUNIX).

NCT ID: NCT03809546 Completed - Clinical trials for Differential Female Response to ?9-tetrahydrocannabinol (THC)

Individual Differences in Drug Response

IDT
Start date: November 6, 2018
Phase: Early Phase 1
Study type: Interventional

Females are increasingly using cannabis, yet remain underrepresented in preclinical and clinical cannabinoid research. This female-specific research plan will test the effects of two recreationally relevant doses of oral THC and placebo in healthy females at two phases of the menstrual cycle. Acute oral THC will be administered in a double-blind and counterbalanced design. Menstrual cycle phase will be determined using blood serum analyses of estradiol and progesterone and self-reported responses. The main hypothesis is circulating estradiol levels are associated with cardiac, neuroendocrine, and subjective THC response. The rationale for the presented work is to better understand the risks of cannabis use, in order to maximize possible medical potential and minimize public health risks. The expected outcome of this work is a deeper understanding of how circulating estradiol levels may associate with response to THC and how the physiological response is associated with the subjective response. Uncovering the individual differences in response to THC will allow for more preventive action against cannabis-induced anxiety, paranoia, and psychosis.

NCT ID: NCT03808727 Completed - Clinical trials for PTSD, Post Traumatic Stress Disorder

Massed Cognitive Processing Therapy for Combat-related PTSD

Start date: March 5, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if cognitive processing therapy (CPT) delivered in a massed format (MCPT) is as effective as standard delivery of CPT. MCPT will be delivered in an intensive outpatient setting (12 sessions in 5 days) composed of both group and individual sessions. Standard delivery of CPT consists of 12 sessions over 6 weeks and involves only individual sessions. Assessment of PTSD and related symptoms will be conducted at pre-treatment and 1 month and 4 months following treatment in both conditions. Additionally, in order to compare the treatment groups at the same point in actual time, each group will be assessed at the one month posttreatment time point for the other condition.

NCT ID: NCT03808272 Completed - Clinical trials for Pancreatic Pseudocyst and Walled-off Necrosis

AXIOS CHINA (E7148)

Start date: April 17, 2019
Phase: N/A
Study type: Interventional

To study the safety and effectiveness of the AXIOS Stent with Electrocautery Enhanced Delivery System for endoscopic trans enteric drainage of pancreatic pseudocyst and walled-off necrosis in Chinese population, to support the regulatory approval by CFDA

NCT ID: NCT03807895 Completed - Clinical trials for Psychological Distress

REBT Intervention Program for Career Decision-making Difficulties in High School Pupils

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

Career decision-making difficulties are frequent problems for adolescents. Regular intervention or prevention programs mainly provide information for the students about themselves, about the world of work, about their interests and preferences etc. Rational emotive behavioral therapy (REBT), a form of Cognitive behavioral therapy (CBT) provides help for adolescents to efficiently cope with emotional problems (e.g., psychological distress) related to the career decision-making process. The present study aims to investigate the efficiency of an REBT career intervention program implemented in a school setting. School settings are appropriate to deliver group intervention for students. Classes from Romanian public high-schools will be randomized in either intervention or treatment as usual groups.

NCT ID: NCT03807882 Completed - Clinical trials for Treatment Resistant Schizophrenia

Comparison of Maintenance ECT Versus Clozapine in Treatment-resistant Schizophrenia

Start date: February 1, 2019
Phase: Phase 4
Study type: Interventional

The proposed study will be conducted to compare the efficacy of maintenance ECT (M-ECT) vs Clozapine in treatment resistant schizophrenia (TRS) in terms of change in psychopathology measures and cerebral hemodynamics.

NCT ID: NCT03807804 Completed - Clinical trials for Respiratory Distress Syndrome, Adult

Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome

ONE-BRIDGE
Start date: January 1, 2019
Phase: Phase 2
Study type: Interventional

The primary object of this clinical study is to investigate the efficacy of HLCM051 in patients with ARDS caused by pneumonitis.

NCT ID: NCT03807622 Completed - Clinical trials for Patient With Clinically Indicated Invasive Monitoring

ClearSight System CHN Study

Start date: December 25, 2018
Phase:
Study type: Observational

The purpose of this clinical trial is to demonstrate that cardiac output (CO) as determined with the Clinical Platform (Model:EV1000A, Software Version:1.9) in a noninvasive manner is comparable to CO as determined by Pulmonary Artery Catheter (PAC) thermodilution (TD). The results of this study may be used for registration and regulatory submissions.

NCT ID: NCT03807375 Completed - Clinical trials for Time to Reach 90% Endtidal Oxygen During Preoxygenation

The Comparison of the Methods Applied in Bariatric Surgery in Terms of Preoxygenation Time

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

The aim of the study was to evaluate the preoxygenation time by observing patients undergoing preoxygenation with CPAP (Continuous Positive Airway Pressure) and Mask Ventilation in the clinic.

NCT ID: NCT03807076 Completed - Clinical trials for Acromegaly Due to Pituitary Adenoma

Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor

GA-9
Start date: August 13, 2019
Phase: N/A
Study type: Interventional

Modulation of the GIP System in Patients With Acromegaly Due to a Pituitary adenoma